De Vuyst P - Search Results

1

The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor.

Hollevoet K, Nackaerts K, Thas O, Thimpont J, Germonpré P, De Vuyst P, Bosquée L, Legrand C, Kellen E, Kishi Y, Delanghe JR, van Meerbeeck JP. Hollevoet K, et al. Among authors: de vuyst p. Chest. 2012 Feb;141(2):477-484. doi: 10.1378/chest.11-0129. Epub 2011 Jul 7. Chest. 2012. PMID: 21737491

2

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.

Hollevoet K, Nackaerts K, Thimpont J, Germonpré P, Bosquée L, De Vuyst P, Legrand C, Kellen E, Kishi Y, Delanghe JR, van Meerbeeck JP. Hollevoet K, et al. Among authors: de vuyst p. Am J Respir Crit Care Med. 2010 Mar 15;181(6):620-5. doi: 10.1164/rccm.200907-1020OC. Epub 2010 Jan 14. Am J Respir Crit Care Med. 2010. PMID: 20075387

3

Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study.

Hollevoet K, Van Cleemput J, Thimpont J, De Vuyst P, Bosquée L, Nackaerts K, Germonpré P, Vansteelandt S, Kishi Y, Delanghe JR, van Meerbeeck JP. Hollevoet K, et al. Among authors: de vuyst p. J Thorac Oncol. 2011 May;6(5):889-95. doi: 10.1097/JTO.0b013e31820db377. J Thorac Oncol. 2011. PMID: 21358346 Free article.

4

Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.

Hollevoet K, Nackaerts K, Gosselin R, De Wever W, Bosquée L, De Vuyst P, Germonpré P, Kellen E, Legrand C, Kishi Y, Delanghe JR, van Meerbeeck JP. Hollevoet K, et al. Among authors: de vuyst p, de wever w. J Thorac Oncol. 2011 Nov;6(11):1930-7. doi: 10.1097/JTO.0b013e3182272294. J Thorac Oncol. 2011. PMID: 21841505 Free article.

5

Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades.

Dumortier P, Thimpont J, de Maertelaer V, De Vuyst P. Dumortier P, et al. Among authors: de vuyst p, de maertelaer v. Eur Respir J. 2003 Sep;22(3):519-24. doi: 10.1183/09031936.03.00001903. Eur Respir J. 2003. PMID: 14516145 Free article.

6

[Asbestosis still exists…].

De Vuyst P, Remmelink M, Mekinda Z, Thimpont J, Dumortier P, Gevenois PA. De Vuyst P, et al. Rev Mal Respir. 2012 Nov;29(9):1127-31. doi: 10.1016/j.rmr.2012.04.008. Epub 2012 Jul 23. Rev Mal Respir. 2012. PMID: 23200587 French.

7

Wegener's granulomatosis presenting as acute respiratory failure with anti-neutrophil-cytoplasm antibodies.

Lenclud C, De Vuyst P, Dupont E, Depierreux M, Ketelbant P, Goldman M. Lenclud C, et al. Among authors: de vuyst p. Chest. 1989 Aug;96(2):345-7. doi: 10.1378/chest.96.2.345. Chest. 1989. PMID: 2666045

8

Environmental asbestosis complicated by lung cancer.

De Vuyst P, Dumortier P, Jacobovitz D, Emri S, Cöplü L, Baris YI. De Vuyst P, et al. Chest. 1994 May;105(5):1593-5. doi: 10.1378/chest.105.5.1593. Chest. 1994. PMID: 8181367

9

Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Discrepancies between lung biopsy and bronchoalveolar lavage findings.

Leduc D, De Vuyst P, Lheureux P, Gevenois PA, Jacobovitz D, Yernault JC. Leduc D, et al. Among authors: de vuyst p. Chest. 1993 Nov;104(5):1620-3. doi: 10.1378/chest.104.5.1620. Chest. 1993. PMID: 8222842

10

High-altitude pulmonary edema with primary pulmonary hypertension.

Naeije R, De Backer D, Vachiéry JL, De Vuyst P. Naeije R, et al. Among authors: de backer d, de vuyst p. Chest. 1996 Jul;110(1):286-9. doi: 10.1378/chest.110.1.286. Chest. 1996. PMID: 8681646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters